Science Explorer Back to mapMap
Discussion
Researcher · Dr. Mohan's Diabetes Specialities Centre · India

Saravanan Jebarani

Saravanan Jebarani publishes mostly in Endocrinology, Diabetes and Metabolism, Genetics and Surgery, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Diabetes and associated disorders.

ORCID 0000-0002-2890-9246 OpenAlex
World rank
#1,467,300
of 7,710,434 ranked researchers
Rank in India
#23,062
of 280,097
Works
50
Citations
1.1k
Citations per work
21.5
h-index
16
i10-index 20Top 32% in Endocrinology, Diabetes and Metabolism
Saravanan Jebarani

What does Saravanan Jebarani research?

Saravanan Jebarani's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 28 works · 56.2% of their workMedicine: 28 works · 56.2% of their workEndocrinology, Diabetes and Metabolism: 19 works · 38.0% of their workSurgery: 4 works · 7.7% of their workEpidemiology: 3 works · 5.6% of their workOphthalmology: 2 works · 4.9% of their workEverything else: 14 works · 28.3% of their workLife Sciences: 8 works · 15.5% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 15.5% of their workGenetics: 5 works · 9.9% of their workMolecular Biology: 3 works · 5.6% of their workTHEIR WORKSaravananJebarani50works
Life Sciences16%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2856.2%
  2. Everything else1428.3%
    1. Biochemistry, Genetics and Molecular Biology815.5%
  1. 1Endocrinology, Diabetes and Metabolism38% of their works
  2. 2Genetics10% of their works
  3. 3Surgery8% of their works
  4. 4Epidemiology6% of their works
  5. 5Molecular Biology6% of their works
  6. 6Ophthalmology5% of their works

Research topics

Which keywords describe Saravanan Jebarani's research?

The keywords of their largest research topics: Cardiovascular Disease, Diabetes, Glycemic Control, Insulin Therapy, Insulin Resistance, Metabolic Syndrome, Type 1 Diabetes and Glucose Metabolism.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Cardiovascular Disease292 topics
  2. Diabetes292 topics
  3. Glycemic Control262 topics
  4. Insulin Therapy262 topics
  5. Insulin Resistance242 topics
  6. Metabolic Syndrome242 topics
  7. Type 1 Diabetes202 topics
  8. Glucose Metabolism191 topic
  9. Obesity191 topic
  10. Cardiovascular Outcomes161 topic
  11. Type 2 Diabetes161 topic
  12. Autoimmunity101 topic
  13. Continuous Glucose Monitoring101 topic
  14. Genetics101 topic
  15. Hypoglycemia101 topic
  16. AMP-Activated Protein Kinase71 topic
  17. Metformin71 topic
  18. Pancreatic Islets61 topic
  19. ß-Cell Dysfunction61 topic
  20. NAFLD51 topic
  21. NASH51 topic
  22. Genetic Variation41 topic
  23. Genome-Wide Association41 topic

Where does Saravanan Jebarani work?

Saravanan Jebarani's main affiliation in the publication record is Dr. Mohan's Diabetes Specialities Centre, India.

How many publications and citations does Saravanan Jebarani have?

OpenAlex counts 50 works and 1,077 citations for Saravanan Jebarani, an h-index of 16, ranking #1,467,300 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Saravanan Jebarani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.